Pular para o conteúdo principal

ETHNOS_APP

Início • Busca • Periódicos • Lista 0

Jean van Wyk

Dados Biográficos

ID7730473
NOMEJean van Wyk
PRENOMESJean
SOBRENOMEvan Wyk
ASSINATURAVAN WYK J
AFILIAÇÕESViiV Healthcare (United Kingdom)
ORCID0000-0001-5719-7949
VERIFICADOSim
TOTAL DE OBRAS3
TOTAL DE CITAÇÕES0
TOTAL COMO AUTOR3
TOTAL COMO EDITOR0
PRIMEIRO ANO DE PUBLICAÇÃO2014
ANO MAIS RECENTE DE PUBLICAÇÃO2024
ÍNDICE H0
  • Improvements in Patient-Reported Outcomes After 12 Months of Maintenance Therapy With Cabotegravir + Rilpivirine Long-Acting Compared With Bictegravir/Emtricitabine/Tenofovir Alafenamide in the Phase …

    Open Access•Cristina Mussini, Charles Cazanave et al.•ARTICLE•AIDS and Behavior•2024

    SOLAR (NCT04542070; registered 2020-09-09) is a Phase 3b study that demonstrated the noninferior virological efficacy of switching to cabotegravir + rilpivirine long-acting (CAB + RPV LA) dosed every 2 months vs. continuing daily oral bictegravir/emtricitabine/tenofovir alafenamide (BIC/FTC/TAF) over 12 months. Participants were randomised (2:1) to switch to CAB + RPV LA or to continue BIC/FTC/TAF. Patient-reported endpoints included treatment pr…

  • Barriers to access to care reported by women living with HIV across 27 countries

    Margaret Johnson, Anna Samarina et al.•ARTICLE•AIDS Care•2015

    Increased access to successful antiretroviral therapy (ART) is necessary in order to achieve an AIDS-free generation. Importantly, slightly over half of the people living with HIV are women. Small studies have described many barriers to accessing treatment and care among women living with HIV. This cross-sectional, non-interventional, epidemiological study assessed the prevalence of barriers to accessing care for women living with HIV across 27 c…

  • Screening for neurocognitive impairment, depression, and anxiety in HIV-infected patients in Western Europe and Canada

    Kevin Robertson, Carmen Bayón et al.•ARTICLE•AIDS Care•2014

    CRANIum, a cross-sectional epidemiology study in Western Europe and Canada, was conducted to describe and compare the prevalence of a positive screen for neurocognitive impairment (NCI), depressive symptoms, and anxiety in an HIV-positive population either receiving combination antiretroviral therapy (cART) or who were naive to antiretroviral therapy (ART). HIV-positive patients ≥18 years of age attending a routine medical follow-up visit and abl…

Sem obras proeminentes nesta página.

  • Screening for neurocognitive impairment, depression, and anxiety in HIV-infected patients in Western Europe and Canada

    Kevin Robertson, Carmen Bayón et al.•ARTICLE•AIDS Care•2014

    CRANIum, a cross-sectional epidemiology study in Western Europe and Canada, was conducted to describe and compare the prevalence of a positive screen for neurocognitive impairment (NCI), depressive symptoms, and anxiety in an HIV-positive population either receiving combination antiretroviral therapy (cART) or who were naive to antiretroviral therapy (ART). HIV-positive patients ≥18 years of age attending a routine medical follow-up visit and abl…

  • Barriers to access to care reported by women living with HIV across 27 countries

    Margaret Johnson, Anna Samarina et al.•ARTICLE•AIDS Care•2015

    Increased access to successful antiretroviral therapy (ART) is necessary in order to achieve an AIDS-free generation. Importantly, slightly over half of the people living with HIV are women. Small studies have described many barriers to accessing treatment and care among women living with HIV. This cross-sectional, non-interventional, epidemiological study assessed the prevalence of barriers to accessing care for women living with HIV across 27 c…

  • Improvements in Patient-Reported Outcomes After 12 Months of Maintenance Therapy With Cabotegravir + Rilpivirine Long-Acting Compared With Bictegravir/Emtricitabine/Tenofovir Alafenamide in the Phase …

    Open Access•Cristina Mussini, Charles Cazanave et al.•ARTICLE•AIDS and Behavior•2024

    SOLAR (NCT04542070; registered 2020-09-09) is a Phase 3b study that demonstrated the noninferior virological efficacy of switching to cabotegravir + rilpivirine long-acting (CAB + RPV LA) dosed every 2 months vs. continuing daily oral bictegravir/emtricitabine/tenofovir alafenamide (BIC/FTC/TAF) over 12 months. Participants were randomised (2:1) to switch to CAB + RPV LA or to continue BIC/FTC/TAF. Patient-reported endpoints included treatment pr…

HIV Research and Treatment (3 obras) · Medicine (3 obras) · Antiretroviral therapy (2 obras) · HIV/AIDS Research and Interventions (2 obras) · Internal Medicine (2 obras) · Psychiatry (2 obras) · Viral load (2 obras) · Anxiety (1 obras) · Cart (1 obras) · Cognition (1 obras)

Ethnos_APP • Projeto Open Source • Licença MIT • Frontend v2.0.0 • Privacidade e Cookies • Documentação da API: api.ethnos.app/docs • Código da API: GitHub • DOI: 10.5281/zenodo.17049435 • Código do Frontend: GitHub • DOI: 10.5281/zenodo.17050053 • cruz.rio.br • Expectantes Misericordiae